Blackstone’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$459K Buy
+7,608
New +$422K ﹤0.01% 370

Other funds holding XENE

Blackstone's XENE Position: Q2 2026 in Review

Blackstone opened a new position in Xenon Pharmaceuticals (XENE) in Q2 2026: 7,608 shares worth $459K. The stake represents ﹤0.01% of the portfolio and ranks #370 among its holdings.

316 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Blackstone held 7,608 shares of Xenon Pharmaceuticals worth $459K as of Q2 2026.
  • Xenon Pharmaceuticals was a new Blackstone position in Q2 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #370 holding.
  • 316 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.